サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1533896

アムロジピンベシル酸塩の世界市場

Amlodipine Besylate

出版日
ページ情報
英文 177 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
アムロジピンベシル酸塩の世界市場
出版日: 2024年08月14日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 177 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

アムロジピンベシル酸塩の世界市場は2030年までに13億米ドルに達する

2023年に12億米ドルと推定されるアムロジピンベシル酸塩の世界市場は、2023年から2030年にかけてCAGR 2.1%で成長し、2030年には13億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである高血圧アプリケーションは、CAGR 2.3%を記録し、分析期間終了時には5億9,980万米ドルに達すると予測されます。心臓病アプリケーション分野の成長率は、分析期間中CAGR 2.4%と推定されます。

米国市場は3億1,460万米ドルと推定、中国はCAGR4.3％で成長予測

米国のアムロジピンベシル酸塩市場は、2023年に3億1,460万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに2億6,130万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは4.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ0.5％と1.5％と予測されています。欧州では、ドイツがCAGR 1.0%で成長すると予測されています。

世界のアムロジピンベシル酸塩市場- 主な促進要因と動向のまとめ

アムロジピンは、主に高血圧（高血圧症）や狭心症（胸痛）の治療に用いられるカルシウム拮抗薬です。心筋細胞や平滑筋細胞へのカルシウムイオンの流入を阻害することで、アムロジピンは血管を弛緩・拡張させ、血流を改善し、心臓の仕事量を減少させる。この作用機序により、アムロジピンは脳卒中、心臓発作、および高血圧に伴うその他の心血管系疾患の予防に効果的な治療薬となります。アムロジピンは1日1回の経口錠剤として処方されることが多く、単独または他の降圧薬と併用することができます。

イントロダクション以来、アムロジピンの使用は著しく拡大し、その有効性と安全性は多くの研究によって検証されています。アムロジピンは現在、世界的に最も一般的に処方されている高血圧治療薬のひとつです。アムロジピンの人気の一因は、他の高血圧治療薬に比べて副作用が比較的軽く、長期使用に適していることです。さらに、アムロジピンは単独療法としても、ACE阻害薬や利尿薬など他の薬剤との併用療法としても汎用性があるため、臨床現場での有用性が高まっています。また、アムロジピンのジェネリック医薬品が開発されたことで、アムロジピンの入手が容易になり、価格も手頃になったことも、その普及に寄与しています。高血圧や狭心症の治療に加え、現在進行中の調査では、冠動脈疾患やその他の心血管系疾患の管理における役割など、アムロジピンの新たな適応の可能性が模索されています。

アムロジピン市場の成長は、いくつかの要因によってもたらされます。第一に、世界の高血圧と心血管疾患の有病率の増加が、効果的な降圧薬に対する需要を大幅に押し上げています。第二に、高血圧や関連疾患に罹患しやすい世界人口の高齢化が、アムロジピンのような治療薬の必要性をさらに高めています。さらに、製薬研究の継続的な進歩により、患者のコンプライアンスと治療成果を高める改良型製剤や併用療法が開発されています。また、新興市場におけるヘルスケア・インフラの拡充も、高血圧治療へのアクセスを改善し、市場の成長を促進しています。さらに、製薬企業による戦略的なマーケティング活動や教育的取り組みによって、高血圧管理に対する意識が高まり、より多くの患者が治療を受けるようになっています。最後に、良好な規制環境とジェネリック医薬品の増加により、アムロジピンはより入手しやすくなり、市場の持続的成長に寄与しています。

調査対象企業の例（注目の36社）

  • Amsal Chem Pvt. Ltd.
  • Apotex Inc.
  • Cadila Pharmaceuticals Ltd.
  • Century Pharmaceuticals Ltd.
  • Changzhou Yabang Pharmaceutical Co. Ltd.
  • Cipla Ltd
  • Dr. Reddys Laboratories Ltd.
  • Lupin Pharmaceuticals, Inc.
  • Midas Pharma GmbH
  • MOEHS IBERICA SL
  • Orbion Pharmaceuticals Pvt. Ltd.
  • Pfizer Inc.
  • Strides Pharma Science Ltd
  • Teva Pharmaceutical USA, Inc.
  • Zydus Pharmaceuticals, Inc.;

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP26609

Global Amlodipine Besylate Market to Reach US$1.3 Billion by 2030

The global market for Amlodipine Besylate estimated at US$1.2 Billion in the year 2023, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 2.1% over the analysis period 2023-2030. High Blood Pressure Application, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$599.8 Million by the end of the analysis period. Growth in the Heart Disease Application segment is estimated at 2.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$314.6 Million While China is Forecast to Grow at 4.3% CAGR

The Amlodipine Besylate market in the U.S. is estimated at US$314.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$261.3 Million by the year 2030 trailing a CAGR of 4.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.5% and 1.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.0% CAGR.

Global Amlodipine Besylate Market - Key Drivers and Trends Summarized

Amlodipine is a calcium channel blocker medication primarily used to treat high blood pressure (hypertension) and angina (chest pain). By inhibiting the influx of calcium ions into cardiac and smooth muscle cells, amlodipine helps relax and widen blood vessels, improving blood flow and reducing the heart's workload. This mechanism of action makes it an effective treatment for preventing strokes, heart attacks, and other cardiovascular issues associated with hypertension. Available in various dosages, amlodipine is often prescribed as a once-daily oral tablet and can be used alone or in combination with other antihypertensive agents.

The use of amlodipine has expanded significantly since its introduction, with numerous studies validating its efficacy and safety. It is now one of the most commonly prescribed medications for managing hypertension globally. The drug's popularity is partly due to its relatively mild side effect profile compared to other antihypertensives, making it suitable for long-term use. Moreover, the versatility of amlodipine, both as a monotherapy and in combination with other medications like ACE inhibitors or diuretics, has enhanced its utility in clinical practice. The development of generic versions of amlodipine has also made it more accessible and affordable, contributing to its widespread adoption. In addition to treating hypertension and angina, ongoing research is exploring potential new indications for amlodipine, such as its role in managing coronary artery disease and other cardiovascular conditions.

The growth in the amlodipine market is driven by several factors. Firstly, the increasing prevalence of hypertension and cardiovascular diseases worldwide has significantly boosted the demand for effective antihypertensive medications. Secondly, the aging global population, which is more prone to hypertension and related disorders, has further escalated the need for treatments like amlodipine. Additionally, the continuous advancement in pharmaceutical research has led to the development of improved formulations and combination therapies that enhance patient compliance and therapeutic outcomes. The expansion of healthcare infrastructure in emerging markets has also improved access to hypertension treatments, thereby driving market growth. Furthermore, strategic marketing efforts and educational initiatives by pharmaceutical companies have raised awareness about hypertension management, encouraging more patients to seek treatment. Finally, favorable regulatory environments and the increasing availability of generic versions have made amlodipine more accessible, contributing to its sustained market growth.

Select Competitors (Total 36 Featured) -

  • Amsal Chem Pvt. Ltd.
  • Apotex Inc.
  • Cadila Pharmaceuticals Ltd.
  • Century Pharmaceuticals Ltd.
  • Changzhou Yabang Pharmaceutical Co. Ltd.
  • Cipla Ltd
  • Dr. Reddys Laboratories Ltd.
  • Lupin Pharmaceuticals, Inc.
  • Midas Pharma GmbH
  • MOEHS IBERICA SL
  • Orbion Pharmaceuticals Pvt. Ltd.
  • Pfizer Inc.
  • Strides Pharma Science Ltd
  • Teva Pharmaceutical USA, Inc.
  • Zydus Pharmaceuticals, Inc.;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Amlodipine Besylate - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Hypertension and Cardiovascular Diseases Drives Demand for Amlodipine Besylate
    • Advancements in Drug Formulation Enhance Efficacy and Patient Compliance
    • Increasing Geriatric Population Boosts Market Growth for Amlodipine Besylate
    • Growing Awareness of Hypertension Management Expands Market Opportunities
    • Development of Combination Therapies with Amlodipine Besylate Attracts Consumer Interest
    • Personalized Medicine Trends Create New Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Amlodipine Besylate Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Amlodipine Besylate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Amlodipine Besylate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Amlodipine Besylate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for High Blood Pressure Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for High Blood Pressure Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for High Blood Pressure Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Heart Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Heart Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Heart Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Amlodipine Besylate by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Amlodipine Besylate by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Amlodipine Besylate by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Amlodipine Besylate by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Amlodipine Besylate by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Amlodipine Besylate by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Amlodipine Besylate by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Amlodipine Besylate by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Amlodipine Besylate by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Amlodipine Besylate by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Amlodipine Besylate by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Amlodipine Besylate by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION